Biotech Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations July 18, 2022
Biotech EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update July 18, 2022
Biotech Eton Pharmaceuticals Announces FDA Approval of ZONISADE(TM) (Zonisamide Oral Suspension) July 18, 2022
Biotech Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position July 18, 2022
Biotech Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals July 18, 2022
Biotech Evelo Biosciences Announces Appointment of Marella Thorell as Chief Financial Officer July 18, 2022
Biotech EyePoint Pharmaceuticals (EYPT) Soars 21.6%: Is Further Upside Left in the Stock? July 18, 2022